LCTX
Price
$1.69
Change
-$0.03 (-1.74%)
Updated
Oct 3 closing price
Capitalization
385.92M
31 days until earnings call
MGNX
Price
$1.78
Change
+$0.07 (+4.09%)
Updated
Oct 3 closing price
Capitalization
112.51M
37 days until earnings call
Interact to see
Advertisement

LCTX vs MGNX

Header iconLCTX vs MGNX Comparison
Open Charts LCTX vs MGNXBanner chart's image
Lineage Cell Therapeutics
Price$1.69
Change-$0.03 (-1.74%)
Volume$2.21M
Capitalization385.92M
MacroGenics
Price$1.78
Change+$0.07 (+4.09%)
Volume$735.51K
Capitalization112.51M
LCTX vs MGNX Comparison Chart in %
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. MGNX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a StrongBuy and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (LCTX: $1.69 vs. MGNX: $1.78)
Brand notoriety: LCTX and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 145% vs. MGNX: 97%
Market capitalization -- LCTX: $385.92M vs. MGNX: $112.51M
LCTX [@Biotechnology] is valued at $385.92M. MGNX’s [@Biotechnology] market capitalization is $112.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while MGNX’s TA Score has 6 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 3 bearish.
  • MGNX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а -1.17% price change this week, while MGNX (@Biotechnology) price change was +2.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

LCTX is expected to report earnings on Nov 05, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($386M) has a higher market cap than MGNX($113M). LCTX YTD gains are higher at: 236.318 vs. MGNX (-45.231). LCTX has higher annual earnings (EBITDA): -19.77M vs. MGNX (-26.91M). MGNX has more cash in the bank: 176M vs. LCTX (42.3M). LCTX has less debt than MGNX: LCTX (2.15M) vs MGNX (37.2M). MGNX has higher revenues than LCTX: MGNX (164M) vs LCTX (10.9M).
LCTXMGNXLCTX / MGNX
Capitalization386M113M342%
EBITDA-19.77M-26.91M73%
Gain YTD236.318-45.231-522%
P/E RatioN/AN/A-
Revenue10.9M164M7%
Total Cash42.3M176M24%
Total Debt2.15M37.2M6%
FUNDAMENTALS RATINGS
LCTX vs MGNX: Fundamental Ratings
LCTX
MGNX
OUTLOOK RATING
1..100
4326
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3550
P/E GROWTH RATING
1..100
5995
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (55) in the null industry is in the same range as MGNX (81) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGNX’s over the last 12 months.

LCTX's Profit vs Risk Rating (77) in the null industry is in the same range as MGNX (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGNX’s over the last 12 months.

LCTX's SMR Rating (98) in the null industry is in the same range as MGNX (98) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGNX’s over the last 12 months.

LCTX's Price Growth Rating (35) in the null industry is in the same range as MGNX (50) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGNX’s over the last 12 months.

LCTX's P/E Growth Rating (59) in the null industry is somewhat better than the same rating for MGNX (95) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXMGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANKOF0.200.01
+3.40%
Angkor Resources Corp.
ALOD0.25N/A
N/A
Allied Resources, Inc.
LFCBY17.00N/A
N/A
Lifco AB
EBRPF21.00N/A
N/A
Ebro Foods SA
KHTRF4.24-0.18
-4.07%
Knight Therapeutics Inc

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-1.74%
MDGL - LCTX
43%
Loosely correlated
-1.47%
PYXS - LCTX
35%
Loosely correlated
+14.22%
ELVN - LCTX
34%
Loosely correlated
-1.56%
MGNX - LCTX
33%
Loosely correlated
+4.09%
AXON - LCTX
33%
Loosely correlated
-0.70%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+4.09%
RGNX - MGNX
52%
Loosely correlated
-1.42%
CRBU - MGNX
52%
Loosely correlated
+1.79%
XNCR - MGNX
52%
Loosely correlated
-0.42%
BEAM - MGNX
49%
Loosely correlated
+0.63%
ARWR - MGNX
48%
Loosely correlated
+4.39%
More